Formulation of pyridoxine hydrochloride sustained release capsules: Effect of propylene glycol co-solvent on the in vitro release

Abstract

The objectives of the present study were to formulate sustained release pyridoxine hydrochloride capsules and to study the effect of propylene glycol co-solvents on the in vitro properties of the capsules. All batches of formulations were made with fixed concentrations of binder-disintegrants, diluents and equal load of active pharmaceutical ingredient. The granules were prepared by wet granulation using propylene glycol water co-solvent as the wetting agent, sodium carboxymethylcellulose (SCMC) and maize starch were used as binder-disintegrant and kaolin was used as the diluents. The micromeritic properties of the granules were analysed by direct and indirect methods. The granules were encapsulated in hard gelatin capsule No. 1. The capsule weight uniformity, disintegration time and drug content were determined. In vitro dissolution test was performed in 0.1 N HCl, simulated gastric fluid (SGF, pH 1.2) and simulated intestinal fluid (SIF, pH 7.2). The results showed that the particles size of granules ranged from 245 to 259 µm and had good flowability. The capsules complied with British Pharmacopoeia (BP) requirement for capsule weight uniformity. The drug content was within 90 to 110% of the average values. The results of in vitro drug release in SGF (pH, 1.2) showed that the release of pyridoxine hydrochloride was very slow and was significantly (P < 0.05) lower than the release in 0.1 N HCl and in SIF (pH, 7.2), respectively. Therefore, pyridoxine hydrochloride sustained release capsules could be formulated with kaolin as the diluent and propylene glycol co-solvent as the moistening agent in order to reduce the frequency of administration of this drug and improve patient compliance.

Preparation, characterization and utilization of coreshell super paramagnetic iron oxide nanoparticles for curcumin delivery

“…Pyridoxine hydrochloride dissolves chitosan, moreover it is biocompatible. Pyridoxine, a water soluble vitamin involves in amino-acid, carbohydrate and fat metabolism and is also required for the formation of haemoglobin when given as hydrochloride [ 23 ]. Pyridoxine is usually given orally–the preferred route–and may also be given subcutaneous, intramuscular, or intra venous routes [ 24 ].…”

Anti-Inflammatory and Gastroprotective Properties of Aspirin - Entrapped Solid Lipid Microparticles

“…The zero order plots (Fig. 4a ) of the amount released and time were linear only for Batch C (R 2 = 0.9) [ 78 , 79 ]. The first order plots (Fig.…”

“…The flow properties of the dried SLM were analysed by the indirect method earlier reported [ 78 , 79 ]. The bulk and tapped densities were determined and used in calculating the Hausner’s quotient and Carr’s compressibility index [ 80 , 81 ].…”

Multifunctional Clay in Pharmaceuticals

“…The rate of drug release is pH dependent [54]. The sustained release formulation of pyridoxine hydrochloride (vitamin B6) was prepared by using kaolin as diluent [55]. Vitamin drugs degrade easily in the presence of high moisture content since kaolin exhibit low moisture content the formulation containing vitamin B1 (thiamine) and Vitamin C (ascorbic acid) is more stable on addition of kaolin than other additives [56,57].…”